PositoAI/ US/ SCYNEXIS, Inc.

SCYNEXIS, Inc.

NasdaqCM: SCYX · Healthcare

Positivity Index

#2,295 / 6,774

Global

#688 / 4,000

United States

Positivity Score

21,677

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

SCYNEXIS, Inc. — Overview & Financial Snapshot

SCYNEXIS, Inc. (NasdaqCM: SCYX) is a Healthcare company, ranked #2,295 of 6,774 companies globally and #688 of 4,000 in United States on PositoAI, with a Positivity Score of 21,677. Its market capitalisation is ₹357.82 Cr ($37.91M), P/E ratio is -4.3 and P/B ratio is 0.57. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

P/B Ratio 0.57

P/E Ratio -4.3

D/E Ratio 0.03

ROE -18.38%

Owes vs Owns ? 0.11× Low $0.11 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-84.01$-0.89

Forward EPS ₹-218.51$-2.32

Beta 1.06

Market Cap ₹357.82 Cr$37.91M

What these numbers mean →

What does SCYNEXIS, Inc. do?

What is SCYNEXIS, Inc.'s P/E and P/B ratio?

SCYNEXIS, Inc. has a P/E ratio of -4.3 and a P/B ratio of 0.57.

What is SCYNEXIS, Inc.'s debt-to-equity ratio?

SCYNEXIS, Inc. has a debt-to-equity ratio of 0.03.

How much does SCYNEXIS, Inc. owe compared with what it owns?

SCYNEXIS, Inc. owes $0.11 for every $1 it owns (balance sheet Jun 2026), which is low.

What is SCYNEXIS, Inc.'s Positivity rank?

SCYNEXIS, Inc. is ranked #2,295 of 6,774 companies globally and #688 of 4,000 in United States on PositoAI, with a Positivity Score of 21,677.

Does SCYNEXIS, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for SCYNEXIS, Inc..

Where can I read the latest news about SCYNEXIS, Inc.?

Recent headlines about SCYNEXIS, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does SCYNEXIS, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of SCYNEXIS, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.